Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen versus fresh frozen plasma in traumatic hemorrhagic shock
IRCT20150704023046N4Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2019
- Modality
- Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-blind trial of Fibrinogen human, fresh-frozen plasma and red blood cells in hemorrhagic shock and Hypotensive shock (3 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Blood pressure, pH level and 4 more. Started Mar 2019; status: completed.
02
Drugs
Fibrinogen humanfresh-frozen plasmared blood cells
03
Conditions
hemorrhagic shockHypotensive shock
Beyond the preview
Go deeper on IRCT20150704023046N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150704023046N4.